Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. Berndt Axel Edvard ModigCo-Founder, CEO & Executive Director | -2,29k | 71,17k | Automatic Disposition | 31,05 - 31,46 | 1,09M | -0,21% |
| 2026-06-12 | Dr. Peng LuPresident | -117,00 | 3,77k | Sale to Issuer | 32,20 | 65,63k | -0,18% |
| 2026-06-11 | Dr. Peng LuPresident | -109,00 | 3,43k | Sale to Issuer | 31,51 | 65,75k | -0,17% |
| 2026-06-04 | Ms. Anna NijdamHead of Strategic Finance & Principal Accounting Officer | -2,67k | 82,43k | Verkauf | 30,87 | 46,28k | -5,46% |
| 2026-05-15 | Dr. Robert GlassmanIndependent Non-Executive Director | -4,67k | 139,15k | Verkauf | 29,82 | 10,50k | -30,77% |
| 2026-05-15 | Dr. Robert GlassmanIndependent Non-Executive Director | -5,33k | 40,11k | Derivative Exercise and Sale | 22,31 - 29,83 | 10,50k | - |
| 2026-05-15 | Mr. Wim SouverijnsChief Commercial Officer | -10,00k | 299,16k | Automatic Disposition | 29,92 | 45,11k | -18,15% |
| 2026-05-11 | Dr. Peng LuPresident | -226,00 | 6,78k | Sale to Issuer | 29,95 - 30,09 | 65,86k | -0,34% |
| 2026-04-29 | Mr. Hans J. G. C. P. SchikanIndependent & Non-Executive Vice Chair | -32,90k | 996,54k | Automatic Disposition | 30,07 - 31,03 | 355,17k | -8,48% |
| 2026-04-29 | Dr. Anne A. LesageChief Early Development Officer | -22,90k | 692,14k | Automatic Disposition | 30,06 - 30,26 | 190,42k | -10,74% |
| 2026-04-29 | Dr. Anne A. LesageChief Early Development Officer | -25,40k | 603,77k | Derivative Exercise and Sale | 2,59 - 30,26 | 190,42k | - |
| 2026-04-29 | Dr. Peng LuPresident | -18,73k | 517,34k | Derivative Exercise and Sale | 2,59 - 30,24 | 66,08k | - |
| 2026-04-22 | Mr. Hans J. G. C. P. SchikanIndependent & Non-Executive Vice Chair | -7,10k | 213,38k | Automatic Disposition | 30,03 - 30,05 | 388,07k | -1,80% |
| 2026-04-22 | Dr. Anne A. LesageChief Early Development Officer | -7,10k | 213,36k | Verkauf | 30,03 - 30,05 | 178,10k | -3,83% |
| 2026-04-22 | Dr. Anne A. LesageChief Early Development Officer | -7,60k | 170,46k | Derivative Exercise and Sale | 2,59 - 30,05 | 178,10k | - |
| 2026-04-22 | Dr. Peng LuPresident | -7,10k | 195,01k | Derivative Exercise and Sale | 2,59 - 30,05 | 66,08k | - |
| 2026-04-16 | Dr. Peng LuPresident | -226,00 | 6,50k | Sale to Issuer | 28,78 | 66,08k | -0,34% |
| 2026-04-16 | Mr. Berndt Axel Edvard ModigCo-Founder, CEO & Executive Director | -2,29k | 65,56k | Automatic Disposition | 28,60 | 1,09M | -0,21% |
| 2026-04-11 | Ms. Anna NijdamHead of Strategic Finance & Principal Accounting Officer | -548,00 | 14,59k | Sale to Issuer | 26,63 | 48,94k | -1,11% |
| 2026-04-09 | Mr. Berndt Axel Edvard ModigCo-Founder, CEO & Executive Director | -23,33k | 647,28k | Automatic Disposition | 27,74 - 28,42 | 1,09M | -2,09% |
| 2026-04-06 | Ms. Anna NijdamHead of Strategic Finance & Principal Accounting Officer | -1,17k | 33,33k | Sale to Issuer | 28,56 | 49,49k | -2,30% |
| 2026-04-01 | Ms. Anna NijdamHead of Strategic Finance & Principal Accounting Officer | -1,16k | 32,88k | Sale to Issuer | 28,25 | 50,66k | -2,25% |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
